Holder Nevins, Msph
About Holder Nevins, Msph
Holder Nevins, MSPH, serves as the Director of Global Insights & Analytics at Kite Pharma. With extensive experience in commercial strategy and analytics across various companies, he possesses a strong background in both qualitative and quantitative research methods.
Current Role at Kite Pharma
Holder Nevins serves as the Director of Global Insights & Analytics at Kite Pharma. He has been in this role for 10 months, working on-site in Santa Monica, California. In this position, he focuses on leveraging insights and analytics to drive strategic decisions within the organization.
Previous Experience at Amgen
Holder Nevins has extensive experience at Amgen, where he held multiple roles over several years. He worked as the Associate Director of Immunology Commercial Insights for 3 months in 2023. Prior to that, he served as the Commercial Insights Lead for Enbrel, Avsola, and Amjevita from 2019 to 2023, totaling 4 years in this capacity. His work at Amgen included a focus on commercial strategy and analytics for Enbrel from 2018 to 2019.
Experience at QuintilesIMS
Nevins worked at QuintilesIMS in various capacities. He was a Senior Manager in Market Research from 2014 to 2015 for 8 months and later served as Consultant III from 2015 to 2016 for 1 year. His roles at QuintilesIMS contributed to his expertise in market research and analytics.
Background in Project Management
Holder Nevins began his career at CE Outcomes, LLC, where he worked as a Project Manager from 2009 to 2011 for 2 years. He later advanced to Senior Manager of Assessment and Analytics at the same company from 2011 to 2014 for 3 years. This experience provided him with a solid foundation in project management and analytics.
Education and Expertise
Holder Nevins holds a Bachelor of Science in Biology from the University of Montevallo. He also earned a Master of Science in Public Health (MSPH) with a focus on Outcomes Research from the University of Alabama at Birmingham, School of Public Health. His educational background supports his expertise in both qualitative and quantitative research methods in the healthcare and pharmaceutical sectors.